![]() ![]() ![]() Traditional synthesis methods produce a single gene in the same physical space using a 96-well plate. #Twist bioscience full#This miniaturization allows us to reduce the reaction volumes by a factor of 1,000,000 while increasing throughput by a factor of 1,000, enabling the synthesis of 9,600 genes on a single silicon chip at full scale. Twist Bioscience has industrialized the production of cost-effective, high-fidelity, high- throughput DNA, which is delivered to customers via seamless online. Twist Bioscience developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a high-throughput silicon platform that allows us to miniaturize the chemistry necessary for DNA synthesis. TWIST have industrialized the production of cost-effective, high-fidelity, high-throughput DNA, which is delivered to our customers via seamless Online Ordering. Applying rigorous engineering principles to harness the highly-scalable production and processing infrastructure of the semiconductor industry allows us to achieve precision in manufacturing DNA at scale. Twist Bioscience developed the DNA Synthesis Platform to address the limitations of throughput, scalability and cost inherent in legacy DNA synthesis methods. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.TWIST Bioscience created a revolutionary silicon-based DNA synthesis platform, that offers precision at a scale otherwise unavailable to our customers. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist Bioscience is a synthetic biology company based in South San Francisco, California. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by "writing" DNA on a silicon chip. Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The webcast replay will be available for two weeks. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. The press release with the financial results will be accessible from the company’s website prior to the conference call through the Investor Relations section under the "Company" tab at The conference call will be webcast live through the Investor Relations section under the "Company" tab at Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here. #Twist bioscience update#Eastern Time to discuss its financial results and provide an update on the company’s business. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. SOUTH SAN FRANCISCO, Calif., July 18, 2022-( BUSINESS WIRE)-Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2022 third quarter ended June 30, 2022, before the opening of the market on Aug. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |